Our funding partners play a crucial role in fueling scientific breakthroughs and discoveries. OCC thanks our funding partners for maximizing our impact, propelling innovative studies, and driving progress for ovarian cancer research.

Cancer Research Society

In 2014, OCC and CRS established a granting framework for its largest ongoing research investment, with a dedicated category for ovarian cancer research. Since 2021, this collaboration has expanded to include two strategic competitions focused on ovarian cancer.

Heath Canada / Santé Canada

Health Canada

In 2019, OCC successfully advocated and received a historic $10 million investment in ovarian cancer research by Health Canada. Tremendous progress has been made with his five-year funding.


OCC joined forces with IRICoR, a leader in drug discovery, in 2021 to launch the pan-Canadian LeadAction Ovarian Cancer Competition that would invest $2.3M for the development of new ovarian cancer treatments.

Nova Scotia

Government of Nova Scotia

Funded by a $1 million investment from the Government of Nova Scotia, OCC is leading new research initiatives to fill gaps in treatment and access, identify novel treatment opportunities, and empower leading minds from Nova Scotia.

Government of Saskatchewan

Funded by a $1 million investment from the Government of Saskatchewan, OCC is working with researchers at the University of Saskatchewan and the Saskatchewan Cancer Agency to build on existing health care systems and programs to address ovarian cancer.

FUND RESEARCH that transforms lives.